CLASS II Drug recall · Reported 5 Sep 2018 · FDA Enforcement Report

Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd recalled

Pharmcore is recalling Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd, distributed nationwide in the US. The recall was initiated on 2 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: IPA3-17 Exp. 07/2018
Quantity recalled6 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1153-2018
FDA event ID
80699
Recalling firm
Pharmcore, Hallandale Beach, FL
Classification
Class II
Status
Terminated
Recall initiated
2 Aug 2018
FDA classified
28 Aug 2018
Reported
5 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

2 Aug 2018Recall initiated by company
28 Aug 2018Classified by FDA+26 days
5 Sep 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of sterility.

Which lots are affected?

Lot: IPA3-17 Exp. 07/2018

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

8 other products · FDA event 80699

More recalls from Pharmcore

All 9